// App-Quantinova.ai

28 : Combining the quantitative fecal immunochemical test and full blood count to rule out colorectal cancer in a symptomatic patient referral pathway.

Researchers

Presenter

  • Mark Johnstone

Principal Investigators

  • Paul Burton

  • Georgios Kourounis

  • Jack Winter

  • Emilia M. Crighton

  • David Mansouri

  • Paul Witherspoon

  • Karen Smith

  • Stephen Thomas McSorley

Medical Centers

  • Academic Unit of Colorectal Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom

  • NHS Greater Glasgow & Clyde, Glasgow, United Kingdom

  • Academic Unit of Surgery, Glasgow, United Kingdom

  • Department of Coloproctology, Glasgow, United Kingdom

  • Public Health Screening Unit, Greater Glasgow and Clyde, Glasgow, United Kingdom

  • Academic Unit of Surgery, University of Glasgow, Glasgow, United Kingdom

  • Department of Coloproctology, Glasgow, United Kingdom

  • Department of Clinical Biochemistry, Glasgow, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A